Clinical Trials Logo

Clinical Trial Summary

An Open-label, 2-period, Single-sequence, Crossover Study to Evaluate the Effect of Multiple Oral Dosing of Itraconazole on BCT197 Systemic Exposure in Healthy Male Participants.

Clinical Trial Description

This will be an open label study conducted in healthy male participants at a single centre. Each participant will participate in a screening visit and 2 study periods. At the first study period, all participants will receive a single dose of BCT197 and at study period 2, all participants will receive 14 daily doses of itraconazole and a single dose of BCT197. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03498170
Study type Interventional
Source Mereo BioPharma
Status Completed
Phase Phase 1
Start date March 19, 2018
Completion date May 9, 2018

See also
  Status Clinical Trial Phase
Completed NCT02926326 - The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers Phase 1
Completed NCT01482117 - The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers N/A
Completed NCT01447472 - -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms Phase 1
Completed NCT02067936 - Walking the Isobole of Drug Interaction N/A